Gilead to Acquire Arcellx in US$7.8 Billion Bet on Cancer Therapy
Gilead Sciences (NASDAQ:GILD) will acquire cancer immunotherapy partner Arcellx (NASDAQ:ACLX) in a deal worth up
Pinnacle Amends Payment Terms for El Potrero Project
(TheNewswire) ‘Robert Archer, President and CEO of Pinnacle stated, ‘We are very appreciative of the opportunity
East Nordeau Zone on Globex Royalty Claims Returns High-Grade Gold Drill Results
GLOBEX MINING ENTERPRISES INC. (GMX Toronto Stock Exchange, G1MN Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz,
Nuvau Minerals Announces Amendment to Private Placement Terms
Nuvau Minerals Inc. (TSXV: NMC,OTC:NMCPF) (the ‘Company’ or ‘Nuvau’) announces that, further to its news release